This study explores the impacts of TRPV4 on aortic stiffness and cell heterogeneity in atherosclerosis, indicating its significance in disease progression.
Key Points
TRPV4 deficiency results in a 4-fold reduction in atherosclerotic plaque formation compared to control mice.
Analysis shows a 6-fold increase in aortic root stiffness in mice with TRPV4, highlighting its role in stiffening.
Single-nucleus RNA sequencing reveals significant transcriptional reprogramming in macrophages and endothelial cells due to TRPV4 absence.
Targeting TRPV4-mediated mechanosensing may provide a new therapeutic approach to combat atherosclerosis.